Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates.
about
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interactionTyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence.Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120Multiple blocks to human immunodeficiency virus type 1 replication in rodent cellsSimian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry.N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5).The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies.Susceptibility of HIV type 2 primary isolates to CCR5 and CXCR4 monoclonal antibodies, ligands, and small molecule inhibitorsPeptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1Human CRM1 augments production of infectious human and feline immunodeficiency viruses from murine cells.Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokinesA new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling.Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus.Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles.Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domainsEffect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses.Continued utilization of CCR5 coreceptor by a newly derived T-cell line-adapted isolate of human immunodeficiency virus type 1An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virusCCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates.An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
P2860
Q21245210-643C9771-9EEA-4E77-A93C-9F2DC4051C7DQ24534959-E1F408B3-801E-4A13-ADC7-C8B82FA456E8Q28344310-9BFED0AD-E29F-462F-87ED-AE2A8C5A9D57Q33603453-74907898-641C-4664-A6E8-4C6B631E05EBQ33787066-796374ED-68EA-4338-8B69-36AF171F7A8EQ33804016-09F7D256-BA31-49A2-B212-617F4F9E1135Q33808920-CA9C29FA-181F-4F91-B9E7-488F361396E2Q33819515-1A90E92F-EFD2-46B1-B283-559B219462E7Q33851094-B764DB49-12B1-438C-B2A8-209044B89997Q35312348-8DE87C98-6DC5-4F0E-BA26-232B8D4E22EFQ35758790-A17D7D48-F21C-4203-8040-16901DDC35F7Q35904711-50FDDDD5-11CF-409F-9E9B-4579B36930D2Q35922555-D91F9477-271E-49DC-8FB8-8D634066220AQ36078450-9DE33808-FF84-4120-8DE6-4F17BB6C9F54Q36363829-2C177B0E-EC9A-43A5-936F-A82AC2868D44Q36369644-D272D731-F8D1-4AFA-92A1-5C95D6F8CA93Q36401287-769EAFFB-E534-4322-8F66-0841BF1BC07FQ37093490-9D486F34-8090-4AA2-A879-AF45DB47E7F0Q37184404-E06734A4-429A-4D66-8C68-1D1E1ECB87A4Q37207862-F617A0E5-D18C-4ADF-B33B-EB814B05C2A0Q39549575-EFF1F8FD-D137-4BD0-A4B0-1616B6A03E9DQ39549670-DFA69C61-6A13-4FB1-9088-A627ED34694AQ39580513-E37775C8-188E-4A55-AE9E-C257773783D4Q39581093-6C9135F7-6445-4D16-832D-0060C8E19653Q39682772-B2513E8E-EB7D-430B-B012-0BCD356C2C3BQ40901260-B9330CD1-0E7A-4F44-ACBD-061525AAEE70Q41345703-E2C861B3-2306-455C-94DC-1617505CABBE
P2860
Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Multiple residues contribute t ...... iciency virus type 1 isolates.
@ast
Multiple residues contribute t ...... iciency virus type 1 isolates.
@en
type
label
Multiple residues contribute t ...... iciency virus type 1 isolates.
@ast
Multiple residues contribute t ...... iciency virus type 1 isolates.
@en
prefLabel
Multiple residues contribute t ...... iciency virus type 1 isolates.
@ast
Multiple residues contribute t ...... iciency virus type 1 isolates.
@en
P2093
P2860
P1433
P1476
Multiple residues contribute t ...... iciency virus type 1 isolates.
@en
P2093
B R Cullen
P D Bieniasz
P2860
P304
P577
1998-03-01T00:00:00Z